For many Americans, donating plasma from their blood — or “plassing” — is the only way to make ends meet. The plasma pharmaceuticals market is booming, but many fear U.S. companies are cutting corners to increase profits. Other Western countries only allow donations once every two weeks, but American centers ask for twice weekly donations, which could have long-term health impacts. Some also suspect that safety screening procedures are lax, putting those who receive the end product at risk. In the past, shady plasma collection practices caused an HIV crisis among hemophiliacs, though that risk has been all but eliminated today.
Source: The Atlantic